The COVID-19 pandemic brought many important changes to modern medicine. While the world is adapting to new ways of life, medicine has been forced to deliver high-quality care while promoting and practicing social distancing. One aspect that has been transformed and propelled years into the future is the delivery of telemedicine.
Your patient is a 36-year-old woman who is struggling to lose weight and is concerned about her risk of heart attack. Recently, she adopted a vegetarian diet that has so far failed to lead to significant weight loss. At a recent check-up, she asks if you think switching to a vegan diet may help her.
In a recent study, researchers examined the impact of discontinuing or maintaining antidepressant therapy in individuals with depression who have considered stopping the use of antidepressants.
A 32-year-old woman presented for evaluation of a new rash on her upper and lower extremities, palms, and soles.
According to the FIDELIO-DKD trial, do you know finerenone’s impact on incidence of the composite cardiovascular outcome? Test your knowledge with our latest pop quiz!
A 9-month-old infant, who was born full term, presented with his parents to our primary care clinic for a well-child visit. He had a history of mild developmental delay in the social and communication domains, which was being monitored without therapy.
Use of Steroidogenic Precursors for Evaluation of Adrenocortical Carcinoma in Adrenal Masses: A Case Series
Approximately 2.5% of adrenal masses represent metastatic disease, and 5% are adrenocortical carcinoma (ACC). Given the poor prognosis associated with ACC, early diagnosis and curative resection are critical.
In this commentary, Diane Vizthum, a nutritionist from Johns Hopkins, outlines the research done on the ketogenic diet, whether it benefits heart health, and which patients may actually benefit from the diet.
A 17-year-old young woman, an immigrant from Venezuela, presented with decreased visual acuity in her right eye. Her medical history was significant for congenital toxoplasmosis with intracranial calcifications and a cataract of the left eye.
While SGLT-2 inhibitors are often used in patients with type 2 diabetes, this class of medication can also be used to treat patients with heart failure. In this Q&A, Jennifer Clements, PharmD, discusses a session she recently presented at ADCES21, on the use of SGLT-2 inhibitors in patients with heart failure.